title: Analysis of hypertrophic and normal scar gene expression with cDNA microarrays.
abstract: Hypertrophic scar is one form of abnormal wound healing. Previous studies have suggested that hypertrophic scar formation results from altered gene expression of extracellular matrix molecules. A broadscale evaluation of gene expression in hypertrophic scars has not been reported. To better understand abnormalities in hypertrophic scar gene expression, we compared messenger RNA expression in hypertrophic scars, normal scars, and uninjured skin with the use of complementary (c)DNA microarrays. Total RNA was extracted from freshly excised human hypertrophic scars, normal scars, or uninjured skin and reverse transcribed into cDNA with the incorporation of [33P] deoxycytidine triphosphate. The resulting radioactive cDNA probes were hybridized onto cDNA microarrays of 4000 genes. Hybridization signals were normalized and analyzed. In the comparison of tissue samples, mean intensities were calculated for each gene within each group (hypertrophic scars, normal scars, and uninjured skin). Ratios of the mean intensities of hypertrophic scars to normal scars, hypertrophic scars to uninjured skin, and normal scars to uninjured skin were generated. A ratio that was greater than 1 indicated upregulation of any particular gene and a ratio that was less than 1 indicated downregulation of any particular gene. Our data indicated that 142 genes were overexpressed and 50 genes were underexpressed in normal scars compared with uninjured skin, 107 genes were overexpressed and 71 were underexpressed in hypertrophic scars compared with uninjured skin, and 44 genes were overexpressed and 124 were underexpressed in hypertrophic scars compared with normal scars. Our analysis of collagen, growth factor, and metalloproteinase gene expression confirmed that our molecular data were consistent with published biochemical and clinical observations of normal scars and hypertrophic scars. cDNA microarray analysis provides a powerful tool for the investigation of differential gene expression in hypertrophic scar samples and either uninjured skin or normal scars. Our data validate the use of this technology for future studies on gene expression during repair processes of normal and abnormal wounds.
authors.affiliation: Department of Surgery, VA Puget Sound Health Care System, Harborview Medical Center, Seattle, USA.
authors.forename: R
authors.initials: R
authors.lastname: Tsou
authors.forename: J K
authors.initials: JK
authors.lastname: Cole
authors.forename: A B
authors.initials: AB
authors.lastname: Nathens
authors.forename: F F
authors.initials: FF
authors.lastname: Isik
authors.forename: D M
authors.initials: DM
authors.lastname: Heimbach
authors.forename: L H
authors.initials: LH
authors.lastname: Engrav
authors.forename: N S
authors.initials: NS
authors.lastname: Gibran
mesh_terms: D000328:Adult; D002675:Child, Preschool; D017439:Cicatrix, Hypertrophic / Q000235:genetics* / Q000503:physiopathology*; D003094:Collagen / Q000096:biosynthesis; D005260:Female; D005786:Gene Expression Regulation; D006133:Growth Substances / Q000096:biosynthesis; D006801:Humans; D008297:Male; D020782:Matrix Metalloproteinases / Q000096:biosynthesis; D008875:Middle Aged; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods*
chemical_list: D006133:Growth Substances; D003094:Collagen; D020782:Matrix Metalloproteinases